ArticleBiomedicines2026
Pan-Cancer Prognostic Analysis of NMDAR Genes Discovered Therapeutic Implications of Neuronal-Cancer Crosstalk Mediator GRIN2A for Small Cell Lung Cancer.
Jiaxun Zhang, Akezhouli Shahatiaili, Yuhan Hou, Ning Zhou, Ke Huang, Xiaojun Wang, Dongmei Wang, Zhentao Yu, Xiaoli Feng, Yibo Gao
Abstract read
In one paragraphArticle in Biomedicines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
10 authors.
Jiaxun ZhangDepartment of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Akezhouli ShahatiailiDepartment of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.ORCID 0009-0001-3792-558X Yuhan HouDepartment of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Ning ZhouDepartment of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Ke HuangDepartment of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Xiaojun WangDepartment of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Dongmei WangDepartment of Neurology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Zhentao YuDepartment of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen 518116, China.
Xiaoli FengDepartment of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.ORCID 0000-0001-5663-6006 Yibo GaoCentral Laboratory & Shenzhen Key Laboratory of Epigenetics and Precision Medicine for Cancers, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen 518116, China.ORCID 0000-0002-0501-9814 Funding
Aiyou Foundation KY20170CAMS Initiative for Innovative Medicine 2021-I2M-1-067Cooperation Fund of CHCAMS and SZCH CFA202201001, SZ2020ZD001National Natural Science Foundation of China 82122053Shenzhen Clinical Research Center for Cancer No.〔2021〕287Shenzhen High-level Hospital Construction Fund, Sanming Project of Medicine in Shenzhen SZSM202211011Shenzhen High-level Hospital Construction Fund, Sanming Project of Medicine in Shenzhen SZSM202311002, SZSM202111003Shenzhen Science and Technology Program RCJC20221008092811025, ZDSYS20220606101604009
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
cancer neurosciencedrug resistanceGRIN2ANMDA receptorsmall cell lung cancertumor microenvironment
Identifiers
PMID42351624
PMCPMC13296946
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390